South China Morning Post CENTER (0.0) Reliability: 7.5/10

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

✍️ Eric Ng 📅 January 19, 2019 12:33 PM 🕐 Scraped: October 01, 2025

Summary: Beijing wants cheaper, better drugs. That’s pressuring drug makers to innovate as generics become more competitive.

China’s pharmaceutical industry – shaken by drastic price cuts from Beijing’s recent pilot roll-out of state hospital bulk purchase open bidding – will need to go through painful restructuring and raise b

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Eric Ng

Original Publisher

🌍 South China Morning Post

CENTER Bias (0.0)

Published Date

January 19, 2019 at 12:33 PM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only